OcuMension secures Alcon eye drop rights with 16.7% stake, marking major strategic shift
OcuMension Therapeutics has struck a landmark deal with Alcon Inc., acquiring commercialization rights for a portfolio of eye care products in China. In exchange, OcuMension ... Read More
Quantum Capital Group to acquire Cogentrix Energy from Carlyle Group for $3bn
Quantum Capital Group, a prominent investment firm, has announced it will acquire Cogentrix Energy, a major U.S. independent power producer, from funds managed by Carlyle ... Read More